IMMUNOLOGICAL REACTIONS TO BLOOD AND BLOOD PRODUCTSHILGARD P.1979; BRIT. J. ANAESTH.; GBR; DA. 1979; VOL. 51; NO 1; PP. 45-49; BIBL. 12 REF.Article

DEVELOPPEMENT ET DISSEMINATION DES TUMEURS MALIGNES ET HEMOSTASE = TUMOR GROWTH, TUMOR DISSEMINATION AND HEMOSTASISKHER A; HILGARD P.1983; SEMAINE DES HOPITAUX; ISSN 0037-1777; FRA; DA. 1983; VOL. 59; NO 17; PP. 1348-1354; ABS. FRE/ENG; BIBL. 53 REF.; GRAPH, FIGArticle

MECHANISM OF LUNG TUMOUR COLONY REDUCTION CAUSED BY COUMARIN ANTICOAGULATIONHILGARD P; MAAT B.1979; EUROP. J. CANCER; GBR; DA. 1979; VOL. 15; NO 2; PP. 182-187; BIBL. 19 REF.Article

FACTOR X-ACTIVATING ACTIVITY FROM LEWIS LUNG CARCINOMAHILGARD P; WHUR P.1980; BRIT. J. CANCER; GBR; DA. 1980; VOL. 41; NO 4; PP. 642-643; BIBL. 7 REF.Article

ACTIVATION OF FIBRINOLYSIS BY A LYMPHOGENIC ACTIVATOR IN THE RATHILGARD P; HOHAGE R.1972; LYMPHOLOGY; GERM.; DA. 1972; VOL. 5; NO 4; PP. 152-155; BIBL. 8 REF.Serial Issue

ANTICOAGULANTS AND EXPERIMENTAL METASTASES: EVALUATION OF ANTIMETASTATIC EFFECTS IN DIFFERENT MODEL SYSTEMSMAAT B; HILGARD P.1981; J. CANCER RES. CLIN. ONCOL.; ISSN 0171-5216; DEU; DA. 1981; VOL. 101; NO 3; PP. 275-283; BIBL. 2 P.Article

TRANSIENT BLEOMYCIN-INDUCED THROMBOCYTOPENIA A CLINICAL STUDYHILGARD P; HOSSFELD DK.1978; EUROP. J. CANCER; GBR; DA. 1978; VOL. 14; NO 11; PP. 1261-1264; BIBL. 15 REF.Article

LOW-DOSE HEPARIN IN THE MANAGEMENT OF ACUTE MYELOCYTIC LEUKAEMIANOWROUSIAN MR; HILGARD P.1978; BLUT; DEU; DA. 1978; VOL. 37; NO 6; PP. 341-343; ABS. GER; BIBL. 7 REF.Article

L'ANEMIA EMOLITICA MICROANGIOPATICA = L'ANEMIE HEMOLYTIQUE MICROANGIOPATHIQUEHILGARD P; HIEMEYER V.1972; MINERVA MED.; ITAL.; DA. 1972; VOL. 63; NO 58; PP. 3138-3142; BIBL. 11/2P.Serial Issue

MONOCLONAL CRYOGLOBULIN OF IGG (LAMBDA ) TYPE INTERACTING WITH TRANSFERRINHILGARD P; LINDER KH; WETTER O et al.1981; BLUT; ISSN 0006-5242; DEU; DA. 1981; VOL. 43; NO 4; PP. 217-225; BIBL. 19 REF.Article

FUNZIONE PIASTRINICA E RETINOPATIA DIABETICA = FONCTION DES PLAQUETTES ET RETINOPATHIE DIABETIQUEPORTA M; HILGARD P; KOHNER EM et al.1979; MINERVA ENDOCRINOL.; ITA; DA. 1979; VOL. 4; NO 3; PP. 169-170; BIBL. 7 REF.Article

MICROANGIOPATHIC HAEMOLYTIC ANAEMIA IN CANCER PATIENTS WITH BONE MARROW INFILTRATIONFIRUSIAN N; HILGARD P; FAIDAS G et al.1978; Z. KREBSFORSCH. KLIN. ONKOL.; DEU; DA. 1978; VOL. 92; NO 3; PP. 295-299; BIBL. 18 REF.Article

FAKTOR-XII-MANGEL BEI ZWEI BRUEDERN = DEFICIT DE FACTEUR XII CHEZ 2FRERESMUELLER G; HILGARD P; HIEMEYER V et al.1973; DTSCHE MED. WSCHR.; DTSCH.; DA. 1973; VOL. 98; NO 6; PP. 267-269; BIBL. 12REF.Serial Issue

ORAL ANTICOAGULATION IN THE TREATMENT OF A SPONTANEOUSLY METASTASISING MURINE TUMOUR (3LL).HILGARD P; SCHULTE H; WETZIG G et al.1977; BRIT. J. CANCER; G.B.; DA. 1977; VOL. 35; NO 1; PP. 78-85; BIBL. 12 REF.Article

THROMBIN-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION IN THE DOG. II. CARDIORESPIRATORY CHANGES DURING SPONTANEOUS AND CONTROLLED VENTILATION = COAGULATION INTRAVASCULAIRE DISSEMINEE INDIRECTE PAR LA THROMBINE. II. MODIFICATIONS CARDIO-RESPIRATOIRES AU COURS DE LA VENTILATION SPONTANEE ET CONTROLEEJASTRZEBSKI J; HILGARD P; CHAKRABARTI MK et al.1975; BRIT. J. ANAESTH.; G.B.; DA. 1975; VOL. 47; NO 6; PP. 658-666; ABS. FR. ALLEM. ESP.; BIBL. 1P.1/2Article

Oxazaphosphorine toxicity reduction by mesnaHILGARD, P; POHL, J.Cancer treatment reviews. 1990, Vol 17, Num 2-3, pp 217-220, issn 0305-7372, 4 p.Article

UNTERSUCHUNGEN ZUR ¹³¹I-FIBRINOGEN-AUF NAHME DURCH DAS YOSHIDA-SARKOM DER RATTE = RECHERCHES SUR LA FIXATION DE FIBRINOGENE MARQUE AU ¹³¹I PAR LE SARCOME DE YOSHIDA DU RATHEYES H; HILGARD P; SIGMUND E et al.1973; FORTSCHR. GEB. ROENTGENSTRAHL. NUKLEARMED.; DTSCH.; DA. 1973; VOL. 118; NO 1; PP. 86-91; ABS. ANGL.; BIBL. 9 REF.Serial Issue

Induction of tumor cell differentiation by alkylphosphocholines : a new approach for in vitro screeningMAURER, H. R; HILGARD, P.Progress in experimental tumor research. 1992, Vol 34, pp 90-97, issn 0079-6263Article

A new platelet aggregating material (PAM) in an experimentally induced rat fibrosarcomaMOHANTY, D; HILGARD, P.Thrombosis and haemostasis. 1984, Vol 51, Num 2, pp 192-195, issn 0340-6245Article

The tetrazolium dye assay for rapid in vitro assessment of cytotoxicityISELT, M; HOLTEI, W; HILGARD, P et al.Arzneimittel-Forschung. 1989, Vol 39, Num 7, pp 747-749, issn 0004-4172Article

Oxazaphosphorines as biological response modifiers: experimental and clinical perspectivesHILGARD, P; POHL, J; STEKAR, J et al.Cancer treatment reviews. 1985, Vol 12, Num 3, pp 155-162, issn 0305-7372Article

The development of alkylphosphocholines as signal transduction inhibitors : experimental and clinical challengesHILGARD, P; POHL, J; ENGEL, J et al.Journal of cancer research and clinical oncology. 1997, Vol 123, Num 5, pp 286-287, issn 0171-5216Article

Molecular and cellular effects of hexadecylphosphocholine (Miltefosine) in human myeloid leukaemic cell linesBECKERS, T; VOEGELI, R; HILGARD, P et al.European journal of cancer. Part A. 1994, Vol 30, Num 14, pp 2143-2150Article

Bone marrow purging with mafosfamide: a critical surveySINDERMANN, H; PEUKERT, M; HILGARD, P et al.Blut. 1989, Vol 59, Num 5, pp 432-441, issn 0006-5242Article

Evidence of a role for NK cells in oxazaphosphorine-mediated tumor regressionREISSMANN, T; HILGARD, P; VOEGELI, R et al.Journal of cancer research and clinical oncology. 1989, Vol 115, Num 6, pp 525-530, issn 0171-5216Article